Pharmaceutical tablet

- Celgene Corporation
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top perspective view of a pharmaceutical tablet in accordance with the present design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a bottom plan view thereof;

FIG. 4 is a side elevational view thereof;

FIG. 5 is the opposite side elevational view thereof

FIG. 6 is an end elevational view thereof;

FIG. 7 is the opposite end elevational view thereof;

FIG. 8 is a top perspective view of a pharmaceutical tablet in accordance with a second embodiment of the present design;

FIG. 9 is a top plan view thereof;

FIG. 10 is a bottom plan view thereof;

FIG. 11 is a side elevational view thereof;

FIG. 12 is the opposite side elevational view thereof;

FIG. 13 is an end elevational view thereof; and,

FIG. 14 is the opposite end elevational view thereof.

Claims

The ornamental design for a pharmaceutical tablet, as shown and described.

Referenced Cited
U.S. Patent Documents
D31133 July 1899 Lantz
D301764 June 20, 1989 Contractor
D302051 July 4, 1989 Contractor et al.
5770225 June 23, 1998 Parekh et al.
5824338 October 20, 1998 Jacobs et al.
D403396 December 29, 1998 Lundbom et al.
D408910 April 27, 1999 Lundbom
D425614 May 23, 2000 Chen et al.
D430285 August 29, 2000 Chen et al.
D431076 September 19, 2000 Chen
D434846 December 5, 2000 Chen
6165513 December 26, 2000 Dansereau et al.
D459798 July 2, 2002 Desesquelle
D506544 June 21, 2005 Rinker et al.
D515202 February 14, 2006 Chen
D534646 January 2, 2007 Chang et al.
D535021 January 9, 2007 Stawski et al.
D564086 March 11, 2008 Nielsen et al.
D671636 November 27, 2012 Nishino
D735315 July 28, 2015 Bhat
D741990 October 27, 2015 Ramos
D787042 May 16, 2017 Parikh
D787043 May 16, 2017 Parikh
Other references
  • U.S. Appl. No. 29/531,123, filed Jun. 23, 2015, Parikh et al.
  • United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/524,022, dated Apr. 6, 2016.
  • United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/524,022, dated Oct. 18, 2016.
  • United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/524,022, dated Jan. 10, 2017.
  • United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/525,253, dated Apr. 11, 2016.
  • United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/525,253, dated Oct. 18, 2016.
  • United States Patent and Trademark Office, Notice of Allowance issued in U.S. Appl. No. 29/525,253, dated Jan. 13, 2017.
  • United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/531,113, dated Apr. 12, 2016.
  • United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/531,113, dated Oct. 18, 2016.
  • United States Patent and Trademark Office, Notice of Allowance issued in U.S. Appl. No. 29/531,113, dated Jan. 17, 2017.
  • United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/531,123, dated Apr. 11, 2016.
  • United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/531,123, dated Oct. 18, 2016.
Patent History
Patent number: D813372
Type: Grant
Filed: Feb 22, 2017
Date of Patent: Mar 20, 2018
Assignee: Celgene Corporation (Summit, NJ)
Inventors: Darshan Parikh (Bridgewater, NJ), Scott Burnside (Wilmington, NC), Sreenivas S. Bhat (Kendall Park, NJ), Jiping Liu (Basking Ridge, NJ)
Primary Examiner: Charles Hanson
Application Number: 29/594,820
Classifications
Current U.S. Class: Tablet Or Caplet (1) (D24/101)